Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.11.23 | AFT Pharmaceuticals - Global growth despite tough macro environment | 273 | Edison Investment Research | AFT Pharmaceuticals reported solid H124 top-line growth, driven by strong momentum in the Asian and international markets. H124 revenues of NZ$83.6m grew 27.2% from H123, bolstered by 171.4% and 47.8%... ► Artikel lesen | |
27.11.23 | OSE Immunotherapeutics - Collaboration bolsters upcoming Tedopi Phase III | 313 | Edison Investment Research | OSE Immunotherapeutics (OSE) has announced a collaboration with GenDx for the development and validation of a companion diagnostic screening test to support its upcoming Phase III trial for Tedopi,... ► Artikel lesen | |
27.11.23 | ReNeuron Group - H124 results reaffirm focus on CustomEx | 374 | Edison Investment Research | ReNeuron has announced its H124 results (to end-September 2023), reaffirming its commitment to advance CustomEx , its proprietary stem cell-derived exosome delivery platform. The key operational update... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 3.331 |
EVOTEC | 2.670 |
TUI | 2.102 |
NEL | 1.336 |
BAYER | 1.165 |
NVIDIA | 1.162 |
PLUG POWER | 1.160 |
RHEINMETALL | 1.073 |
AMC ENTERTAINMENT | 1.042 |
DEUTSCHE BANK | 982 |
SIEMENS ENERGY | 949 |
RENK GROUP | 882 |
COMMERZBANK | 735 |
REDCARE PHARMACY | 734 |
HEIDELBERGER DRUCK | 710 |
ALIBABA | 694 |
VOLKSWAGEN | 680 |
BARRICK GOLD | 625 |
E.ON | 623 |
BYD | 599 |
RWE | 593 |
TESLA | 583 |
DEUTSCHE LUFTHANSA | 572 |
SIEMENS | 566 |
AIXTRON SE | 562 |